Researchers at Cedars-Sinai have found that a nonabsorbable antibiotic - one that stays in the gut - may be an effective long-term treatment for irritable bowel syndrome (IBS).

The findings, which showed that participants benefited from the antibiotic use even after the course of treatment ended, support previously published research identifying small intestine bacterial overgrowth (SIBO) as a possible cause of the disease.

Sandy Van
sandyprpacific
Cedars-Sinai Medical Center
www.csmc.edu